Tag: longterm
AstraZeneca’s Brilinta won its coveted stroke-prevention nod. Will it be enough...
A few months ago, AstraZeneca’s Brilinta added a new U.S. indication to reduce the chance of a first heart attack or stroke in certain...
ASCO: Roche’s Alecensa stays on top of Xalkori with long-term survival...
Roche made a splash at ASCO three years ago with data showing that its Alecensa could top Pfizer’s Xalkori at keeping ALK-positive lung-cancer at bay....
